首页 > 最新文献

Ugeskrift for laeger最新文献

英文 中文
Diabetic retinopathy. 糖尿病视网膜病变。
Q4 Medicine Pub Date : 2024-09-09 DOI: 10.61409/V04240246
Jakob Grauslund, Nis Andersen, Jens Andresen, Toke Bek, Sara Brandi, Javad Hajari, Søren Tang Knudsen, Caroline Schmidt Laugesen, Majbrit Lind, Mette Slot Nielsen, Katja Schielke, Yousif Subhi

Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.

糖尿病视网膜病变(DR)是糖尿病患者最常见的并发症,为避免严重的视力损失,必须对危及视力的终末期进行筛查。在丹麦,糖尿病视网膜病变筛查是根据以证据为基础的国家指导方针在全国范围内实施的,其中包括使用个性化的筛查间隔时间。治疗适用于增殖性 DR 和糖尿病性黄斑水肿,治疗方式包括视网膜激光疗法、玻璃体内血管静注疗法和玻璃体切除术。在这篇综述中,我们总结了丹麦目前的 DR 筛查和治疗指南。
{"title":"Diabetic retinopathy.","authors":"Jakob Grauslund, Nis Andersen, Jens Andresen, Toke Bek, Sara Brandi, Javad Hajari, Søren Tang Knudsen, Caroline Schmidt Laugesen, Majbrit Lind, Mette Slot Nielsen, Katja Schielke, Yousif Subhi","doi":"10.61409/V04240246","DOIUrl":"https://doi.org/10.61409/V04240246","url":null,"abstract":"<p><p>Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 37","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Homecare, home monitoring, and hospital-at-home. 家庭护理、家庭监控和医院上门服务。
Q4 Medicine Pub Date : 2024-09-09 DOI: 10.61409/V02240158
Thea Kølsen Fischer, Tatjana Jessen Sandreva, Maria Normand Larsen, Maja Kjær Rasmussen, Thyge Lynghøj Nielsen, Maria Lund Christensen, Jeff Kirk Svane, Kristian Kidholm, Charlotte Demuth von Sydow

The Danish healthcare system is currently undergoing a transformation towards increased use of virtual healthcare services. In this review, we propose a structured risk-stratified model to delineate the differences between homecare, homemonitoring, and hospital-at-home, while discussing their current status and addressing barriers hindering the widespread adoption and scaling of home-based care incl. technological limitations, regulatory complexities, and cultural considerations. We advocate for establishing a national central support function to expedite the shift towards home-based care.

丹麦的医疗保健系统目前正在经历一场转型,越来越多地使用虚拟医疗保健服务。在这篇综述中,我们提出了一个结构化的风险分级模型,以划分家庭护理、家庭监护和医院到家之间的差异,同时讨论了它们的现状,并解决了阻碍广泛采用和推广家庭护理的障碍,包括技术限制、监管复杂性和文化因素。我们主张建立一个全国性的中央支持功能,以加快向居家护理的转变。
{"title":"Homecare, home monitoring, and hospital-at-home.","authors":"Thea Kølsen Fischer, Tatjana Jessen Sandreva, Maria Normand Larsen, Maja Kjær Rasmussen, Thyge Lynghøj Nielsen, Maria Lund Christensen, Jeff Kirk Svane, Kristian Kidholm, Charlotte Demuth von Sydow","doi":"10.61409/V02240158","DOIUrl":"https://doi.org/10.61409/V02240158","url":null,"abstract":"<p><p>The Danish healthcare system is currently undergoing a transformation towards increased use of virtual healthcare services. In this review, we propose a structured risk-stratified model to delineate the differences between homecare, homemonitoring, and hospital-at-home, while discussing their current status and addressing barriers hindering the widespread adoption and scaling of home-based care incl. technological limitations, regulatory complexities, and cultural considerations. We advocate for establishing a national central support function to expedite the shift towards home-based care.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 37","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common efficacy measures and measurement instruments lead to more meaningful clinical research. 通用的疗效测量方法和测量工具有助于开展更有意义的临床研究。
Q4 Medicine Pub Date : 2024-09-09 DOI: 10.61409/V12230799
Dorthe B Berthelsen, Linea Rishøj Thorlacius, Bente Villumsen, Gregor Be Jemec, Robin Christensen

This review describes that a core outcome set (COS) represents a consensus-based minimum set of outcomes to be collected and reported in clinical trials involving a particular disease or population. A COS serves as a guideline for global consensus on which outcome domains should be collected in all clinical trials. After defining what to measure, it becomes crucial to reach consensus on how to measure it. This includes the selection of appropriate outcome measurement instruments with credible measurement properties and interpretable thresholds of meaning.

本综述指出,核心结果集(COS)是在涉及特定疾病或人群的临床试验中收集和报告的一套基于共识的最低结果集。核心结果集是全球就所有临床试验应收集哪些结果领域达成共识的指南。在确定要测量什么之后,就如何测量达成共识就变得至关重要。这包括选择具有可信测量特性和可解释意义阈值的适当结果测量工具。
{"title":"Common efficacy measures and measurement instruments lead to more meaningful clinical research.","authors":"Dorthe B Berthelsen, Linea Rishøj Thorlacius, Bente Villumsen, Gregor Be Jemec, Robin Christensen","doi":"10.61409/V12230799","DOIUrl":"https://doi.org/10.61409/V12230799","url":null,"abstract":"<p><p>This review describes that a core outcome set (COS) represents a consensus-based minimum set of outcomes to be collected and reported in clinical trials involving a particular disease or population. A COS serves as a guideline for global consensus on which outcome domains should be collected in all clinical trials. After defining what to measure, it becomes crucial to reach consensus on how to measure it. This includes the selection of appropriate outcome measurement instruments with credible measurement properties and interpretable thresholds of meaning.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 37","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aberrant left atrial chorda in a patient with mitral regurgitation requiring surgery. 一名二尖瓣反流患者左心房绒毛异常,需要手术治疗。
Q4 Medicine Pub Date : 2024-09-09 DOI: 10.61409/V02240132
Marie Øbo Larsen, Frederik Thorgaard Uttenthal, Gennady V Atroshchenko

We present a rare case of an 84-year-old woman with a left atrial chorda. She was admitted with heart failure and echocardiography revealed severe mitral valve insufficiency due to chordal rupture and prolapse of the posterior leaflet. In addition, a left atrial chorda was diagnosed, attached to the anterior leaflet, restricting the valve and contributing to the insufficiency. The patient underwent surgery with the removal of the atrial chorda and insertion of two neochordae and mitral annuloplasty with a ring. Postoperative echocardiography showed a well-functioning valvuloplasty.

我们为大家介绍一例罕见病例,患者是一名 84 岁的女性,患有左心房弦索。她因心力衰竭入院,超声心动图显示,由于弦索破裂和后叶脱垂,她的二尖瓣严重关闭不全。此外,还诊断出左心房脊索与前叶相连,限制了瓣膜,导致瓣膜功能不全。患者接受了手术,切除了心房绒毛,植入了两个新绒毛,并进行了二尖瓣瓣环成形术。术后超声心动图显示瓣膜成形术功能良好。
{"title":"Aberrant left atrial chorda in a patient with mitral regurgitation requiring surgery.","authors":"Marie Øbo Larsen, Frederik Thorgaard Uttenthal, Gennady V Atroshchenko","doi":"10.61409/V02240132","DOIUrl":"10.61409/V02240132","url":null,"abstract":"<p><p>We present a rare case of an 84-year-old woman with a left atrial chorda. She was admitted with heart failure and echocardiography revealed severe mitral valve insufficiency due to chordal rupture and prolapse of the posterior leaflet. In addition, a left atrial chorda was diagnosed, attached to the anterior leaflet, restricting the valve and contributing to the insufficiency. The patient underwent surgery with the removal of the atrial chorda and insertion of two neochordae and mitral annuloplasty with a ring. Postoperative echocardiography showed a well-functioning valvuloplasty.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 37","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe poisoning with semi-synthetic cannabinoids. 半合成大麻素严重中毒。
Q4 Medicine Pub Date : 2024-09-09 DOI: 10.61409/V04240241
Nanna Reiter, Kristian Linnet, Natasja Østermark Andersen, Brian Schou Rasmussen, Marie Klose Nielsen, Karen Reenberg Eriksen, Dorte Fris Palmqvist

Recently, semi-synthetic cannabinoids have entered the illegal market and are produced to mimic the psychoactive effects of tetrahydrocannabinol (THC). This is a case report of a 19-year-old man, who was hospitalized due to severe sedation, hypotension and tachy- and bradycardia after ingestion of the semi-synthetic cannabinoids hexahydrocannabinol (HHC) and hexahydrocannabiphorol (HHC-P) mixed in food. HHC-P, HHC and metabolites were identified in blood samples. The amount of semi-synthetic cannabinoids in illegal products can be high, which can explain the described prolonged clinical effects.

最近,半合成大麻素进入非法市场,其生产目的是模仿四氢大麻酚(THC)的精神活性作用。这是一份关于一名 19 岁男子的病例报告,他在摄入混在食物中的半合成大麻素六氢大麻酚(HHC)和六氢大麻酚(HHC-P)后,因严重镇静、低血压、心动过速和心动过缓而住院治疗。血液样本中鉴定出了 HHC-P、HHC 和代谢物。非法产品中的半合成大麻素含量可能很高,这可以解释所述的长期临床效应。
{"title":"Severe poisoning with semi-synthetic cannabinoids.","authors":"Nanna Reiter, Kristian Linnet, Natasja Østermark Andersen, Brian Schou Rasmussen, Marie Klose Nielsen, Karen Reenberg Eriksen, Dorte Fris Palmqvist","doi":"10.61409/V04240241","DOIUrl":"10.61409/V04240241","url":null,"abstract":"<p><p>Recently, semi-synthetic cannabinoids have entered the illegal market and are produced to mimic the psychoactive effects of tetrahydrocannabinol (THC). This is a case report of a 19-year-old man, who was hospitalized due to severe sedation, hypotension and tachy- and bradycardia after ingestion of the semi-synthetic cannabinoids hexahydrocannabinol (HHC) and hexahydrocannabiphorol (HHC-P) mixed in food. HHC-P, HHC and metabolites were identified in blood samples. The amount of semi-synthetic cannabinoids in illegal products can be high, which can explain the described prolonged clinical effects.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 37","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical spondylotic myelopathy. 颈椎病。
Q4 Medicine Pub Date : 2024-09-02 DOI: 10.61409/V02240149
David Alw Cant, Simon Bøtker Kongsvad Andersen, Kristian Høy

Cervical spondylotic myelopathy (CSM) is a progressive degenerative condition of the cervical spine and the most common cause of spinal cord injury in adults >55 years of age. Degenerative changes in the spine lead to spinal cord compression, resulting in symptoms such as gait instability, loss of dexterity in the hands, weakness, and sensory deficits. Diagnosis is delayed by 2,2-6,3 years and includes clinical examination and imaging such as MRI. Management of CSM is primarily surgical treatment. This review highligths the importance of early recognition and appropriate treatment in optimising patient outcomes.

颈椎脊髓病(CSM)是颈椎的一种进行性退行性病变,也是 55 岁以上成年人脊髓损伤的最常见原因。脊柱退行性病变导致脊髓受压,从而出现步态不稳、双手失去灵活性、无力和感觉障碍等症状。该病的诊断会延迟 2,2-6,3 年,包括临床检查和核磁共振成像等影像学检查。CSM 的治疗方法主要是手术治疗。本综述强调了早期识别和适当治疗对优化患者预后的重要性。
{"title":"Cervical spondylotic myelopathy.","authors":"David Alw Cant, Simon Bøtker Kongsvad Andersen, Kristian Høy","doi":"10.61409/V02240149","DOIUrl":"https://doi.org/10.61409/V02240149","url":null,"abstract":"<p><p>Cervical spondylotic myelopathy (CSM) is a progressive degenerative condition of the cervical spine and the most common cause of spinal cord injury in adults >55 years of age. Degenerative changes in the spine lead to spinal cord compression, resulting in symptoms such as gait instability, loss of dexterity in the hands, weakness, and sensory deficits. Diagnosis is delayed by 2,2-6,3 years and includes clinical examination and imaging such as MRI. Management of CSM is primarily surgical treatment. This review highligths the importance of early recognition and appropriate treatment in optimising patient outcomes.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 36","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helbrede, lindre, trøste – også ved skizofreni. 治疗、舒缓、安慰--也适用于精神分裂症。
Q4 Medicine Pub Date : 2024-09-02 DOI: 10.61409/V205189
Poul Videbech
{"title":"Helbrede, lindre, trøste – også ved skizofreni.","authors":"Poul Videbech","doi":"10.61409/V205189","DOIUrl":"https://doi.org/10.61409/V205189","url":null,"abstract":"","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 36","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rhinitis medicamentosa. 药物性鼻炎
Q4 Medicine Pub Date : 2024-09-02 DOI: 10.61409/V04240252
Joachim Birk Munksgaard, Jacob Jessen Christensen, Kasper Aanæs

Sales of over-the-counter decongestant nasal sprays in Denmark from 2011 to 2023 have doubled. This article highlights the potential risks associated with prolonged use of decongestant nasal sprays, such as rhinitis medicamentosa. We conclude that there is an urgent need for increased patient education on proper use and possible side effects of over-the-counter decongestant nasal sprays, as well as a need for more substantial data on side effects related to decongestant nasal sprays to guide health authorities in future regulation.

从 2011 年到 2023 年,丹麦非处方减充血剂鼻腔喷雾剂的销量翻了一番。本文强调了长期使用减充血剂鼻腔喷雾剂(如药物性鼻炎)的潜在风险。我们的结论是,迫切需要加强对患者的教育,让他们了解正确使用非处方减充血剂鼻腔喷雾剂的方法和可能产生的副作用,同时需要更多有关减充血剂鼻腔喷雾剂副作用的实质性数据,以指导卫生部门今后的监管工作。
{"title":"Rhinitis medicamentosa.","authors":"Joachim Birk Munksgaard, Jacob Jessen Christensen, Kasper Aanæs","doi":"10.61409/V04240252","DOIUrl":"https://doi.org/10.61409/V04240252","url":null,"abstract":"<p><p>Sales of over-the-counter decongestant nasal sprays in Denmark from 2011 to 2023 have doubled. This article highlights the potential risks associated with prolonged use of decongestant nasal sprays, such as rhinitis medicamentosa. We conclude that there is an urgent need for increased patient education on proper use and possible side effects of over-the-counter decongestant nasal sprays, as well as a need for more substantial data on side effects related to decongestant nasal sprays to guide health authorities in future regulation.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 36","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognosis of schizophrenia. 精神分裂症的预后。
Q4 Medicine Pub Date : 2024-09-02 DOI: 10.61409/V02240156
Marie Starzer, Helene Gjervig Hansen, Carsten Hjorthøj, Nikolai Albert, Merete Nordentoft

Psychotic and negative symptoms are core features of schizophrenia but knowledge on the long-term course of these symptoms is lacking. While antipsychotics improve psychotic symptoms, they have limited effect on negative symptoms. Specialized early interventions like OPUS show great effects while ongoing but long-term follow-up indicates no lasting disease-modifying effects. 18% of patients achieved clinical recovery, and 40% obtained symptom remission after 20 years, but high mortality rates and continuous negative symptoms constitute an unmet treatment need, as argued in this review.

精神症状和阴性症状是精神分裂症的核心特征,但对这些症状的长期病程却缺乏了解。抗精神病药物可以改善精神症状,但对阴性症状的作用有限。像 OPUS 这样的早期专业干预在持续进行时效果显著,但长期随访表明,并没有持久的疾病改变效果。18%的患者实现了临床痊愈,40%的患者在20年后症状得到缓解,但正如本综述所述,高死亡率和持续的阴性症状构成了尚未满足的治疗需求。
{"title":"The prognosis of schizophrenia.","authors":"Marie Starzer, Helene Gjervig Hansen, Carsten Hjorthøj, Nikolai Albert, Merete Nordentoft","doi":"10.61409/V02240156","DOIUrl":"https://doi.org/10.61409/V02240156","url":null,"abstract":"<p><p>Psychotic and negative symptoms are core features of schizophrenia but knowledge on the long-term course of these symptoms is lacking. While antipsychotics improve psychotic symptoms, they have limited effect on negative symptoms. Specialized early interventions like OPUS show great effects while ongoing but long-term follow-up indicates no lasting disease-modifying effects. 18% of patients achieved clinical recovery, and 40% obtained symptom remission after 20 years, but high mortality rates and continuous negative symptoms constitute an unmet treatment need, as argued in this review.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 36","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D-assisted surgery for reconstruction in the head and neck area. 头颈部重建的 3D 辅助手术。
Q4 Medicine Pub Date : 2024-09-02 DOI: 10.61409/V04240267
Lasse Østrup Petersen, Birgitte Jul Kiil, Søren Dührr Gade, Anders Mølggard Jakobsen, Andreas Engel Krag

Preoperative virtual surgical planning and the use of 3D-printed patient-specific models and cutting guides are increasingly being used in the reconstruction of mandibular defects with a free bone flap. This technology offers several advantages over conventional surgery, such as reduced operating time, reduced bone flap ischaemia time, and the ability to perform more complex and precise reconstructions. This review presents the evidence supporting 3D-assisted surgery for mandibular defect reconstruction and discusses the utilisation of commercial vendors versus in-house 3D-printing solutions.

在使用游离骨瓣重建下颌骨缺损时,越来越多地使用术前虚拟手术规划、三维打印患者特异性模型和切割指南。与传统手术相比,该技术具有多项优势,如缩短手术时间、减少骨瓣缺血时间,并能进行更复杂、更精确的重建。本综述介绍了支持下颌骨缺损重建三维辅助手术的证据,并讨论了利用商业供应商与内部三维打印解决方案的比较。
{"title":"3D-assisted surgery for reconstruction in the head and neck area.","authors":"Lasse Østrup Petersen, Birgitte Jul Kiil, Søren Dührr Gade, Anders Mølggard Jakobsen, Andreas Engel Krag","doi":"10.61409/V04240267","DOIUrl":"https://doi.org/10.61409/V04240267","url":null,"abstract":"<p><p>Preoperative virtual surgical planning and the use of 3D-printed patient-specific models and cutting guides are increasingly being used in the reconstruction of mandibular defects with a free bone flap. This technology offers several advantages over conventional surgery, such as reduced operating time, reduced bone flap ischaemia time, and the ability to perform more complex and precise reconstructions. This review presents the evidence supporting 3D-assisted surgery for mandibular defect reconstruction and discusses the utilisation of commercial vendors versus in-house 3D-printing solutions.</p>","PeriodicalId":23428,"journal":{"name":"Ugeskrift for laeger","volume":"186 36","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142354740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ugeskrift for laeger
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1